Position in GRFS
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$341,383
-$8,401 QoQ
Shares Held
48,218
+10.6% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 164 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026QRG CAPITAL MANAGEMENT, INC. holds $606,823,434 across 15 Drug Manufacturers - General names. GRFS ranks #15 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
146,305 | $175,482,620 | |
| 2 | JNJ |
Johnson & Johnson
|
440,815 | $111,953,785 | |
| 3 | ABBV |
AbbVie Inc.
|
301,006 | $75,745,149 | |
| 4 | MRK |
Merck & Co., Inc.
|
428,993 | $55,125,600 | |
| 5 | AMGN |
Amgen Inc
|
98,650 | $35,723,138 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
227,523 | $28,745,255 | |
| 7 | NVS |
Novartis AG
|
164,478 | $25,776,992 | |
| 8 | PFE |
Pfizer Inc
|
902,308 | $21,727,576 |
All Filings in GRFS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $341,383 | 48,218 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $349,784 | 43,614 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $310,522 | 33,211 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $438,947 | 44,071 | Shares | Sole | 2025-10-28 | |
| 2023-12-31 | $405,940 | 35,116 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $303,009 | 33,152 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||